Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Landos Biopharma, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
LABP is no longer listed, and 13F filings after Q1 2024 list far fewer holders. See Q1 2024
- Institutional holders
- 0
- −16 vs. Q1 2024
- Shares held
- 0
- −1.62M (−100.0%) vs. Q1 2024
- Total value
- $0
- −$34.9M (−100.0%) vs. Q1 2024
- New holders
- 0
- 0 more added
- Sold out
- 16
- 0 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LABP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 16 | $34.9M |
| Q4 2023 | 10 | $5.58M |
| Q3 2023 | 11 | $5.93M |
| Q2 2023 | 8 | $6.27M |
| Q1 2023 | 20 | $4.63M |
| Q4 2022 | 23 | $7.87M |
| Q3 2022 | 31 | $14.0M |
| Q2 2022 | 35 | $16.4M |
| Q1 2022 | 45 | $35.3M |
| Q4 2021 | 40 | $119.8M |
| Q3 2021 | 35 | $331.1M |
| Q2 2021 | 33 | $261.4M |
| Q1 2021 | 47 | $218.9M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Landos Biopharma, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −1,486,991−100.0% | Sold out |
| Deltec Asset Management LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −18,890−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −14,718−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,537−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −12,604−100.0% | Sold out |
| PenderFund Capital Management Ltd. | 0 | $0 | 0.00% | −9,300−100.0% | Sold out |
| Black Maple Capital Management LP | 0 | $0 | 0.00% | −10,405−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4,084−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −896−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −134−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −59−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −10−100.0% | Sold out |